Skip to main content
SpringerLink
Log in
Book cover

Device Therapy in Heart Failure pp 185–213Cite as

Cardiac Resynchronization Therapy

  • Chapter
  • First Online:

  • 877 Accesses

Part of the book series: Contemporary Cardiology ((CONCARD))

Abstract

A variety of medical therapies are clinically proven to improve symptoms and mortality in heart failure patients. However, some patients remain symptomatic despite optimal medical therapy. A subset of these patients may demonstrate electrical dyssynchrony which may contribute to hemodynamic and clinical deterioration. This chapter reviews the pathophysiology and clinical assessment of dyssynchrony, the clinical indications for cardiac resynchronization therapy, and a description of the devices and programming features currently available to heart failure patients.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Jessup M, Brozena S, Heart failure. N Engl J Med, 2003;348(20): 2007–18.

    Article  PubMed  Google Scholar 

  2. Hunt SA, et al. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation, 2005;112(12): e154–235.

    Article  PubMed  Google Scholar 

  3. Ho KK, et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993;22(4 Suppl A): 6A–13A.

    Article  CAS  PubMed  Google Scholar 

  4. Schocken DD, et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol, 1992;20(2): 301–6.

    Article  CAS  PubMed  Google Scholar 

  5. Ball SG, Cardioprotection and ACE inhibitors. Clin Physiol Biochem, 1992;9(3): 98–104.

    CAS  PubMed  Google Scholar 

  6. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med, 1991;325(5): 293–302.

    Article  Google Scholar 

  7. Boucher M, Ma J, Heart failure: is there a role for angiotensin II receptor blockers? Issues Emerg Health Technol, 2002;38: 1–4.

    PubMed  Google Scholar 

  8. Maggioni AP, et al., Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors. J Am Coll Cardiol, 2002;40(8): 1414–21.

    Article  CAS  PubMed  Google Scholar 

  9. Pfeffer MA, et al., Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med, 2003;349(20): 1893–906.

    Article  CAS  PubMed  Google Scholar 

  10. Fowler MB, Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure. Am J Cardiol, 2004;93(9A): 35B–9B.

    Article  CAS  PubMed  Google Scholar 

  11. Keating GM, Jarvis B, Carvedilol: a review of its use in chronic heart failure. Drugs, 2003;63(16): 1697–741.

    Article  CAS  PubMed  Google Scholar 

  12. Fowler M, Beta-adrenergic blocking drugs in severe heart failure. Rev Cardiovasc Med, 2002;3(Suppl 3): S20–6.

    PubMed  Google Scholar 

  13. Wollert KC, Drexler H, Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world? Circulation, 2002;106(17): 2164–6.

    Article  PubMed  Google Scholar 

  14. Singh BN, CIBIS, MERIT-HF, and COPERNICUS trial outcomes: do they complete the chapter on beta-adrenergic blockers as antiarrhythmic and antifibrillatory drugs? J Cardiovasc Pharmacol Ther, 2001;6(2): 107–10.

    Article  CAS  PubMed  Google Scholar 

  15. Louis A, et al., Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology. Eur J Heart Fail, 2001;3(3): 381–7.

    Article  CAS  PubMed  Google Scholar 

  16. Dieterich HA, Wendt C, Saborowski F, Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure. Fiziol Cheloveka, 2005;31(6): 97–105.

    CAS  PubMed  Google Scholar 

  17. Killip T, Passamani E, Davis K, Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery. Eight years follow-up and survival in patients with reduced ejection fraction. Circulation, 1985;72(6 Pt 2): V102–9.

    CAS  PubMed  Google Scholar 

  18. Myers WO, et al., CASS Registry long term surgical survival. Coronary Artery Surgery Study. J Am Coll Cardiol, 1999;33(2): 488–98.

    Article  CAS  PubMed  Google Scholar 

  19. Baldasseroni S, et al., Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J, 2002;143(3):398–405.

    Article  PubMed  Google Scholar 

  20. Leclercq C, Kass DA, Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am Coll Cardiol, 2002;39(2): 194–201.

    Article  PubMed  Google Scholar 

  21. Prinzen FW, et al., Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol, 1999;33(6): 1735–42.

    Article  CAS  PubMed  Google Scholar 

  22. Rouleau F, et al., Echocardiographic assessment of the interventricular delay of activation and correlation to the QRS width in dilated cardiomyopathy. Pacing Clin Electrophysiol, 2001;24(10): 1500–6.

    Article  CAS  PubMed  Google Scholar 

  23. Auricchio A, et al., Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation, 1999;99(23): 2993–3001.

    CAS  PubMed  Google Scholar 

  24. Gold MR, et al., Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol, 1995;26(4): 967–73.

    Article  CAS  PubMed  Google Scholar 

  25. Bleeker GB, et al., Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol, 2004;15(5): 544–9.

    Article  PubMed  Google Scholar 

  26. Nelson GS, et al., Predictors of systolic augmentation from left ventricular preexcitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation, 2000;101(23): 2703–9.

    CAS  PubMed  Google Scholar 

  27. Packer M, et al., Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med, 1991;325(21):1468–75.

    Article  CAS  PubMed  Google Scholar 

  28. Nelson GS, et al., Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation, 2000;102(25): 3053–9.

    CAS  PubMed  Google Scholar 

  29. Kaji S, et al., Annular geometry in patients with chronic ischemic mitral regurgitation: three-dimensional magnetic resonance imaging study. Circulation, 2005;112(9 Suppl): I409–14.

    PubMed  Google Scholar 

  30. Breithardt OA, Kuhl HP, Stellbrink C, Acute effects of resynchronisation treatment on functional mitral regurgitation in dilated cardiomyopathy. Heart, 2002;88(4): 440.

    Article  CAS  PubMed  Google Scholar 

  31. Breithardt OA, et al., Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol, 2003;41(5): 765–70.

    Article  PubMed  Google Scholar 

  32. Vogt J, et al., Electrocardiographic remodeling in patients paced for heart failure. Am J Cardiol, 2000;86(9, Supplement 1): K152–6.

    Article  Google Scholar 

  33. Donal E, et al., Effects of cardiac resynchronization therapy on disease progression in chronic heart failure. Eur Heart J, 2006;27(9): 1018–25.

    Article  PubMed  Google Scholar 

  34. David D, et al., Diastolic “locking” of the mitral valve: the importance of atrial systole and intraventricular volume. Circulation, 1983;67(3): 640–5.

    CAS  PubMed  Google Scholar 

  35. Gasparini M, et al., Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: The Bi vs Left Ventricular Pacing: An International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Am Heart J, 2006;152(1): 155.e1–155.e7.

    Article  Google Scholar 

  36. Leclercq C, et al., Biventricular vs. left univentricular pacing in heart failure: rationale, design, and endpoints of the B-LEFT HF study. Europace, 2006;8(1): 76–80.

    Article  PubMed  Google Scholar 

  37. Leclercq C, et al., Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation, 2002;106(14): 1760–63.

    Article  PubMed  Google Scholar 

  38. Bax JJ, et al., Cardiac resynchronization therapy: Part 1–issues before device implantation. J Am Coll Cardiol, 2005;46(12): 2153–67.

    Article  PubMed  Google Scholar 

  39. Pitzalis MV, et al., Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. J Am Coll Cardiol, 2005;45(1): 65–9.

    Article  PubMed  Google Scholar 

  40. Marcus GM, et al., Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol, 2005;46(12): 2208–14.

    Article  PubMed  Google Scholar 

  41. Bax JJ, et al., Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. Am J Cardiol, 2003;92(10): 1238–40.

    Article  PubMed  Google Scholar 

  42. Bax JJ, et al., Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol, 2004;44(9): 1834–40.

    Article  PubMed  Google Scholar 

  43. Chung ES, Leon AR, Tavazzi L, Sun J-P, Nihoyannopoulos P, Merlino J, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation, 2008;117:2608–16.

    Article  PubMed  Google Scholar 

  44. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med, Jun 13 2002;346(24):1845–53.

    Article  PubMed  Google Scholar 

  45. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol, Jun 19 2002;39(12):2026–33.

    Article  PubMed  Google Scholar 

  46. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, Apr 14 2005;352(15):1539–49.

    Article  CAS  PubMed  Google Scholar 

  47. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med, Mar 22 2001;344(12):873–80.

    Article  CAS  PubMed  Google Scholar 

  48. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA, May 28 2003;289(20):2685–94.

    Article  PubMed  Google Scholar 

  49. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med, May 20 2004;350(21):2140–50.

    Article  CAS  PubMed  Google Scholar 

  50. Auricchio A, Stellbrink C, Butter C, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol, Dec 17 2003;42(12):2109–16.

    Article  PubMed  Google Scholar 

  51. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol, Oct 15 2003;42(8):1454–59.

    Article  PubMed  Google Scholar 

  52. McAlister, FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, Dryden DM, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction – a systematic review. JAMA, 2007;297:2502–14

    Article  CAS  PubMed  Google Scholar 

  53. Egoavil CA, Ho RT, Greenspon AJ, et al. Cardiac resynchronization therapy in patients with right bundle branch block: Analysis of pooled data from the MIRACLE and Contak CD trials. Heart Rhythm, 2005;2(6):611–5.

    Article  PubMed  Google Scholar 

  54. Bleeker GB, Holman ER, Steendijk P, et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol, 2006;48(11):2243–50.

    Article  PubMed  Google Scholar 

  55. Yu C-M, Chan Y-S, Zhang Q, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol, 2006;48(11):2251–57.

    Article  PubMed  Google Scholar 

  56. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol, Dec 20 2005;46(12):2183–92.

    Article  PubMed  Google Scholar 

  57. Beshai JF, Grimm RA, Nagueh SF, Baker II JH, Beau SL, Greenberg SM, Pires LA, Tchou PJ, for the RethinQ Study Investigators. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med, 2007;357:2461–71.

    Article  CAS  PubMed  Google Scholar 

  58. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol, 2003;91(6, Supplement 1):2–8.

    Article  Google Scholar 

  59. Gasparini M, Auricchio A, Regoli F, et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol, Aug 15 2006;48(4):734–43.

    Article  PubMed  Google Scholar 

  60. Doshi RN, Daoud EG, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol, Nov 2005;16(11):1160–65.

    Article  PubMed  Google Scholar 

  61. Molhoek SG, Bax JJ, Bleeker GB, et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol, Dec 15 2004;94(12):1506–09.

    Article  PubMed  Google Scholar 

  62. Feldman AM, de Lissovoy G, Bristow MR, et al. Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial. J Am Coll Cardiol, Dec 20 2005;46(12):2311–21.

    Article  PubMed  Google Scholar 

  63. Hlatky MA. Cost effectiveness of cardiac resynchronization therapy. J Am Coll Cardiol, Dec 20 2005;46(12):2322–24.

    Article  PubMed  Google Scholar 

  64. Strickberger SA, Conti J, Daoud EG, et al. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation, Apr 26 2005;111(16):2146–50.

    Article  PubMed  Google Scholar 

  65. Leclercq C, et al., Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol, 1998;32(7): 1825–31.

    Article  CAS  PubMed  Google Scholar 

  66. Aranda JM, Jr., et al., Management of heart failure after cardiac resynchronization therapy: integrating advanced heart failure treatment with optimal device function. J Am Coll Cardiol, 2005;46(12): 2193–8.

    Article  PubMed  Google Scholar 

  67. Ammann P, et al., An electrocardiogram-based algorithm to detect loss of left ventricular capture during cardiac resynchronization therapy. Ann Intern Med, 2005;142(12 Pt 1): 968–73.

    PubMed  Google Scholar 

  68. Meluzin J, et al., A fast and simple echocardiographic method of determination of the optimal atrioventricular delay in patients after biventricular stimulation. Pacing Clin Electrophysiol, 2004;27(1): 58–64.

    Article  PubMed  Google Scholar 

  69. Kerlan JE, et al., Prospective comparison of echocardiographic atrioventricular delay optimization methods for cardiac resynchronization therapy. Heart Rhythm, 2006;3(2): 148–54.

    Article  PubMed  Google Scholar 

  70. Morales MA, et al., Atrioventricular delay optimization by Doppler-derived left ventricular dP/dt improves 6-month outcome of resynchronized patients. Pacing Clin Electrophysiol, 2006;29(6): 564–8.

    Article  PubMed  Google Scholar 

  71. Boriani G, et al., Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy: The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study. Am Heart J, 2006;151(5): 1050–58.

    Article  PubMed  Google Scholar 

  72. Sogaard P, et al., Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation, 2002;106(16): 2078–84.

    Article  PubMed  Google Scholar 

  73. Porciani MC, et al., Echocardiographic examination of atrioventricular and interventricular delay optimization in cardiac resynchronization therapy. Am J Cardiol, 2005;95(9): 1108–10.

    Article  PubMed  Google Scholar 

  74. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation, 2008;117:e350–e408.

    Article  PubMed  Google Scholar 

  75. Zipes DP, et al., ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006;114(10): e385–484.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA

    Daniel Frisch MD

  2. Clinical Cardiology Cardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, MA, USA

    Peter J. Zimetbaum MD (Director)

Authors
  1. Daniel Frisch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter J. Zimetbaum MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Beth Israel Deaconess Medical Center, Harvard Medical School, Pilgrim Road 185, Boston, 02215, U.S.A.

    William H. Maisel

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Frisch, D., Zimetbaum, P.J. (2010). Cardiac Resynchronization Therapy. In: Maisel, W. (eds) Device Therapy in Heart Failure. Contemporary Cardiology. Humana Press. https://doi.org/10.1007/978-1-59745-424-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-424-7_7

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-994-9

  • Online ISBN: 978-1-59745-424-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation